长链非编码RNA(lncRNA)在癌症中的作用

doi:10.11904/j.issn.1002-3070.2019.05.017

Abstract

Abstract: LncRNA is easy to detect in tumor tissues and body fluids of cancer patients.When lncRNA is used as a biomarker,it can help the diagnosis and treatment of a variety of cancers.Detection of lncRNA by molecular tools such as real-time PCR can diagnose cancer,and SNPs in lncRNA can also predict cancer risk in patients.Some lncRNAs have been used as therapeutic targets to treat cancer.Therefore,lncRNA plays an important role in the diagnosis,treatment and prognosis of cancer patients.

Key words: Long non coding RNA, Diagnosis, Therapy, Prognosis

CLC Number:

Q522

LI Siwei, PANG Da. Long non-coding RNA(lncRNA)role in cancer[J]. Journal of Practical Oncology, 2019, 33(5): 471-475.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2019.05.017

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2019/V33/I5/471

References

1 Hangauer MJ,Vaughn IW,Mcmanus MT.Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs[J].PLoS Genet,2013,9(6):e1003569.
2 Costa FF.Non-coding RNAs and new opportunities for the private sector[J].Drug Discov Today,2009,14(9/10):446-452.
3 Costa FF.Non-coding RNAs:lost in translation?[J].Gene,2007,386(1/2):1-10.
4 Guttman M,Rinn JL.Modular regulatory principles of large non-coding RNAs[J].Nature,2012,482(7385):339-346.
5 Kurian L,Aguirre A,Sancho-martinez I,et al.Identification of novel long noncoding RNAs underlying vertebrate cardiovascular development[J].Circulation,2015,131(14):1278-1290.
6 Gupta RA,Shah N,Wang KC,et al.Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis[J].Nature,2010,464(7291):1071-1076.
7 Huarte M.The emerging role of lncRNAs in cancer[J].Nat Med,2015,21(11):1253-1261.
8 Deras IL,Aubin SM,Blase A,et al.PCA3:a molecular urine assay for predicting prostate biopsy outcome[J].J Uro,2008,179(4):1587-1592.
9 Xu S,Sui S,Zhang J,et al.Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer[J].Int J Clin Exp Patholy,2015,8(5):4881-4891.
10 Villegas J,Burzio V,Villota C,et al.Expression of a novel non-coding mitochondrial RNA in human proliferating cells[J].Nucleic Acids Re,2007,35(21):7336-7347.
11 Landerer E,Villegas J,Burzio VA,et al.Nuclear localization of the mitochondrial ncRNAs in normal and cancer cells[J].Cell.Oncol,2011,34(4):297-305.
12 Burzio VA,Villota C,Villegas J,et al.Expression of a family of noncoding mitochondrial RNAs distinguishes normal from cancer cells[J].Proc Natl Acad Sci U S A,2009,106(23):9430-9434.
13 Ribeiro KC,Kowalski LP,Latorre MR.Impact of comorbidity,symptoms,and patients' characteristics on the prognosis of oral carcinomas[J].Arch Otolaryngol Head Neck Surg,2000,126(9):1079-1085.
14 Cao L,Xiao PF,Tao YF,et al.Microarray profiling of bone marrow long non-coding RNA expression in Chinese pediatric acute myeloid leukemia patients[J].Oncol Rep,2016,35(2):757-770.
15 Zhuang W,Ge X,Yang S,et al.Upregulation of lncRNA MEG3 promotes osteogenic differentiation of mesenchymal stem cells from multiple myeloma patients by targeting BMP4 transcription[J].Stem Cell,2015,33(6):1985-1997.
16 Yao Y,Ma J,Xue Y,et al.Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152[J].Cancer Lett,2015,359(1):75-86.
17 He X,Tan X,Wang X,et al.C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion[J].Tumour Biol,2014,35(12):12181-12188.
18 Ma MZ,Chu BF,Zhang Y,et al.Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p[J].Cell Death Dis,2015,6:e1583.
19 Zhu HQ,Zhou X,Chang H,et al.Aberrant expression of CCAT1 regulated by c-Myc predicts the prognosis of hepatocellular carcinoma[J].APJCP,2015,16(13):5181-5185.
20 Yang L,Bai HS,Deng Y,et al.High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion[J].Eur Rev Med Pharmacol Sci,2015,19(17):3187-3193.
21 Meseure D,Vacher S,Lallemand F,et al.Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer[J].Br J Cancer,2016,114(12):1395-1404.
22 Chou J,Wang B,Zheng T,et al.MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42[J].Biochem Biophys Res Commun,2016,472(1):262-269.
23 Zhang T,Cao C,Wu D,et al.SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma[J].Tumour Biol,2016,37(2):2379-2385.
24 Peng W,Fan H.Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma[J].Biomed Pharmacother,2015,72:113-118.
25 Wang F,Yuan JH,Wang SB,et al.Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2[J].Hepatology,2014,60(4):1278-1290.
26 Ma MZ,Li CX,Zhang Y,et al.Long non-coding RNA HOTAIR,a c-Myc activated driver of malignancy,negatively regulates miRNA-130a in gallbladder cancer[J].Mol Cancer,2014,13:156.
27 Zhang Z,Weaver DL,Olsen D,et al.Long non-coding RNA chromogenic in situ hybridisation signal pattern correlation with breast tumour pathology[J].J Clin Pathol,2016,69(1):76-81.
28 Liu L,Yan B,Yang Z,et al.ncRuPAR inhibits gastric cancer progression by down-regulating protease-activated receptor-1[J].Tumour Biol,2014,35(8):7821-7829.
29 Shen Z,Li Q,Deng H,et al.Long non-coding RNA profiling in laryngeal squamous cell carcinoma and its clinical significance:potential biomarkers for LSCC[J].PLoS One,2014,9(9):e108237.
30 Benetatos L,Dasoula A,Hatzimichael E,et al.Promoter hypermethylation of the MEG3(DLK1/MEG3)imprinted gene in multiple myeloma[J].Clin Lymphoma Myeloma,2008,8(3):171-175.
31 Lai M C,Yang Z,Zhou L,et al.Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation[J].Medical Oncology,2012,29(3):1810-1816.
32 Ono H,Motoi N,Nagano H,et al.Long noncoding RNA HOTAIR is relevant to cellular proliferation,invasiveness,and clinical relapse in small-cell lung cancer[J].Cancer Med,2014,3(3):632-642.
33 Yan TH,Lu SW,Huang YQ,et al.Upregulation of the long noncoding RNA HOTAIR predicts recurrence in stage Ta/T1 bladder cancer[J].Tumour Biol,2014,35(10):10249-10257.
34 Wu ZH,Wang XL,Tang HM,et al.Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer[J].Oncol Rep,2014,32(1):395-402.
35 Jiang YZ,Liu YR,Xu XE,et al.Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value[J].Cancer Res,2016,76(8):2105-2114.
36 Cheetham SW,Gruhl F,Mattick JS,et al.Long noncoding RNAs and the genetics of cancer[J].Br J Cancer,2013,108(12):2419-2425.
37 Verhaegh GW,Verkleij L,Vermeulen SH,et al.Polymorphisms in the H19 gene and the risk of bladder cancer[J].Eur Urol,2008,54(5):1118-1126.
38 Gail MH.Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk[J].J Natl Cancer Inst Monographs,2008,100(14):1037-1041.
39 Hanna N,Ohana P,Konikoff FM,et al.Phase 1/2a,dose-escalation,safety,pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer[J].Cancer Gene Ther,2012,19(6):374-381.
40 Zhong L,Yuanjie N,Association between lncRNA H19(rs217727,rs2735971 and rs3024270)polymorphisms and the risk of bladder cancer in Chinese population[J].Minerva Urol Nefrol,2019,71:161-167.

[1]	LIU Siwei, CUI Yue, SUN Yuanyuan, HU Jing, ZHANG Wenrui, CAO Mengru. Effect of FOXD3 in lung cancer cells [J]. Journal of Practical Oncology, 2019, 33(5): 390-396.
[2]	XIA Tianyi, ZHANG Bomiao, YAO Kefei, CUI Binbin. Clinical relationship between PTPN9 expression and colorectal cancer [J]. Journal of Practical Oncology, 2019, 33(5): 415-419.
[3]	SHI Manru, E Mingyan. Effect of delayed radiotherapy on the prognosis of patients with different molecular subtypes of breast cancer [J]. Journal of Practical Oncology, 2019, 33(5): 431-435.
[4]	XU Ting, YAN Feifei, ZHANG Chunhui, ZHANG Yanqiao. Analysis of clinical pathology and prognosis in patients with gastric cancer & bone metastasis [J]. Journal of Practical Oncology, 2019, 33(5): 436-441.
[5]	HUANG Xianbo, SHI Ting, YE Xiujin. Progress in the treatment of acute T lymphoblastic leukemia by targeting PI3K/AKT/mTOR pathway [J]. Journal of Practical Oncology, 2019, 33(5): 451-455.
[6]	QU Yanfei, LIU Chao, WANG Bojun, FANG Lin, ZHANG Yanqiao. Expression of CSN6 gene in hepatocellular carcinoma tissues and its clinical significance [J]. Journal of Practical Oncology, 2019, 33(4): 328-333.
[7]	LIU Jintao, GAO Ling, ZHOU Huiui. Expression of MAGEA4 and EB1 proteins in lung cancer tissues and their correlation with clinicopathological features and prognosis [J]. Journal of Practical Oncology, 2019, 33(4): 334-339.
[8]	CHEN Hongbo, YU Zengrong, DING Xiaofan, XIAO Lin. Progress of correlation between bone marrow dose-volume parameters and acute hematologic toxicity in pelvic malignant tumor [J]. Journal of Practical Oncology, 2019, 33(4): 361-366.
[9]	YAO Yang, ZHANG Yanqiao. Mechanism and recent progress of gastric cancer in immunological checkpoint inhibitors [J]. Journal of Practical Oncology, 2019, 33(4): 371-375.
[10]	ZHU Shijia, XU Xiangying. Advance of whole brain radiotherapy irradiation of hippocampus in the treatment of small cell lung cancer [J]. Journal of Practical Oncology, 2019, 33(4): 380-383.
[11]	WANG Xiaoya,XIAO Bin,LIAO Yang,TANG Rongzhi,SUN Zhaohui,LI Linhai. Expression of CXCR family proteins in different subtypes of breast cancer and their clinical prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 206-210.
[12]	LI Jiaqi,LUAN Jinwei,ZHANG Yu,LI Xianglan. Analysis of clinicopathological features,recurrence and metastasis in 763 triple-negative breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 244-249.
[13]	ZHU Lin,ZHANG Chunxia. Research progress of the nano drug-loading systems targeting tumor stem cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 276-279.
[14]	LI Shan,ZHAO Chunbo,QIAO Wenbo. Progress in the application of intraoperative radiotherapy in pancreatic cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 280-283.
[15]	FENG Yue,XING Linan,WANG Zhao,ZHANG Yunyan. Correlation between NLR and prognosis of concurrent chemoradiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 284-288.

Long non-coding RNA(lncRNA)role in cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments